Unlock instant, AI-driven research and patent intelligence for your innovation.

Composition containing sodium hyaluronate and preparation and application thereof

A technology of sodium hyaluronate and composition, which is applied in the field of medicine, can solve the problem that the antibacterial effect needs to be further enhanced, and achieve the effect of improving the antibacterial effect

Active Publication Date: 2020-02-14
中山万远新药研发有限公司
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the antibacterial effect of the patented product 1,3-butanediol combined with sodium hyaluronate needs to be further enhanced

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Composition containing sodium hyaluronate and preparation and application thereof
  • Composition containing sodium hyaluronate and preparation and application thereof
  • Composition containing sodium hyaluronate and preparation and application thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example 1

[0034] The preparation of the sodium hyaluronate of preparation example 1 different molecular weights

[0035] The present invention uses sodium hyaluronate (molecular weight 500kDa-1200kDa) as a raw material (provided by Xi'an Libang Pharmaceutical Co., Ltd.), and adopts gel column chromatography to separate and obtain sodium hyaluronate with different molecular weight distributions. details as follows:

[0036] Take sodium hyaluronate and prepare solution A with a concentration of 2.5 g / L in terms of sodium hyaluronate with 0.2M sodium nitrate solution.

[0037] Boil SephadexG 100 dry powder in boiling water for 3 hours, pack the evenly stirred gel column to 30cm, and then equilibrate with 10 times the volume of 0.2M sodium nitrate solution eluent. Use a pipette to measure 3mL of solution A and add it from the top of the column. Use a constant flow pump to continuously add 0.2M sodium nitrate solution for elution (flow rate 0.5mL / min). Collect the eluate every 3 minutes, ...

preparation example 2

[0040] The synthesis of preparation example 2 caprolactam compounds

[0041] The present invention is based on the compound shown in formula II (R in formula II) recorded in the prior art 1 Same as formula I) as raw materials, and the compound shown in formula I was prepared by referring to the method disclosed in Tetrahedron 54 (1998) 9207-9222, and the specific reaction formula was shown in formula III.

[0042]

preparation example 21

[0043] Preparation Example 2.1 Preparation and structure confirmation of 3-(oct-2-yl)azepan-2-one (compound 2)

[0044] Take 0.5mol of diisopropylamine and 250mL of tetrahydrofuran, place in a three-neck round bottom flask, cool to 0°C, add dropwise a 2.5M n-butyllithium / n-hexane solution with 0.5mol of n-butyllithium content under stirring . After stirring at 0°C for 15 minutes, the reaction solution was cooled to -78°C, and then 0.5 mol of azepan-2-one (compound 1) was slowly added thereto, and after stirring at -78°C for 30 minutes, 0.55 mol octan-2-yl iodide. The mixture was stirred at -30°C for 3 hours and then allowed to warm to room temperature. The lower layer reaction containing the target compound was collected by gentle inclination, then water was added, and the resulting amide was extracted with chloroform. The organic phase was dried over magnesium sulfate, concentrated, and distilled at atmospheric pressure, and the fraction at 182-185°C was collected to obtai...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Molecular weightaaaaaaaaaa
Login to View More

Abstract

The invention relates to the technical field of medicines, and particularly relates to a composition containing sodium hyaluronate and a preparation and application thereof. The composition includes sodium hyaluronate, caprolactam compounds and ethylenediaminetetraacetic acid disodium salt, with an advantage of remarkable bacteriostatic effect.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a composition containing sodium hyaluronate and its preparation and application. Background technique [0002] Allergic diseases may occur in all ages from newborns to the elderly. Among allergic diseases, immediate allergic reactions are more common. The main types are skin allergic reactions, respiratory allergic reactions, digestive tract allergic reactions, and anaphylactic shock. Wait. Allergic conjunctivitis is a common allergic disease. [0003] Infectious diseases are generally caused by bacteria, viruses, fungi or mycoplasma and chlamydia infection. During the period of treatment, the patient is susceptible to other diseases due to poor physical fitness and resistance to germs. For example, people who have just had surgery do not pay attention to disinfection and protection of the incision, and are prone to infection and difficult to heal. [0004] An allergic react...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K47/22A61K47/18A61K31/728A61P31/04A61P37/08
CPCA61K31/728A61K47/183A61K47/22A61P31/04A61P37/08
Inventor 向飞杜志博冯艺虹谭春霞钟明丽杨衍秋彭韪
Owner 中山万远新药研发有限公司